SUPPLEMENTARY METHODS
and the plasmids are low-copy CEN plasmids rather than high-copy 2µ plasmids. Despite these changes, CP1 and CP2 retained similar activity in α-syn-expressing model strains. All mutagenesis was performed using standard site-directed mutagenesis techniques (Quikchange mutagenesis, Stratagene, and similar strategies). Fluorescence and electron microscopy of yeast expressing α-syn and CP contructs was performed as described 4 . We designed the mCP gene to encode the SICLOPPS construct followed by an HA tag and flanked by Gateway cloning sites, and the gene was synthesized from component oligonucleotides (GeneArt, Inc.).
CP1 and CP2 sequences and splice-disabling mutations were introduced using site-directed mutagenesis. LR Clonase reactions were used to transfer the mCP genes to the worm DA-specific expression plasmid pDEST-DAT-1. GFP was introduced by cloning in a GFP cassette between PstI and EcoRI sites downstream of the HA tag.
Preparation of Affinity Reagents
Head-to-tail cyclized peptides were synthesized using standard Fmoc solid-phase chemistry, cyclized prior to side chain deprotection, and purified to 95% by RP-HPLC (Cambridge Peptides, Inc. (Supplementary Fig. 4 ) were reacted with Aminolink Plus Coupling Resin (Pierce) according to manufacturer's instructions. UV spectroscopy indicated that resin was loaded to 1-2 mg per mL of gel bed volume. CP1 R7K and CP2 W7K were also reacted with NHS-LC-Biotin (Pierce) and Sulfo-SBED Biotin Label Transfer Reagent (Pierce) to geneate biotinylated and photo-activatable crosslinking analogs rapidly and with high efficiency.
Generation of CP1-GFP and CP2-GFP transgenic worms
mCP_CP1-GFP and mCP_CP2-GFP were cloned into pDEST-DAT-1 via Gateway technology (Invitrogen, Carlsbad, CA) to selectively express the transgenes in the worm DA neurons under the control of dat-1 promoter. The expression plasmids along with a marker rol-6 (50 μg/ml each plasmid) were directly microinjected into the gonads of wildtype N2 strain to generate UA116 [baEx91; P dat-1 ::mCP1_CP1-GFP; rol-6 (su1006)] and UA117 [baEx92; P dat-1 ::mCP_CP2-GFP; rol-6 (su1006)]. Three independent transgenic worms were generated for each strain. Fluorescence microscopy was performed to verify the expression of CPs as described previously 5 .
SUPPLEMENTARY DATA
Co-expression of selected CPs with established genetic suppressors of α-syn toxicity Two important genetic suppressors of α-syn toxicity uncovered using our yeast model are Ypt1 and Ypk1. Ypt1 is a Rab GTPase involved in ER-to-Golgi transport and Ypk9 is a P-type ATPase with homology to the human PARK9/ATP13A2 gene which is linked to an early-onset form of Parkinsonism. Homologues of both these proteins have been shown to reduce α-syn toxicity in metazoan models including the nematode model 4, 6, 7 . To determine whether CP1 and CP2 act in different pathways from Ypt1 and Ypk9, we expressed them along with the genetic suppressors in a higher-toxicity α-syn strain 4, 7 . Genetic suppressors were cloned into the pAG413GPD yeast expression vector and the CPs were expressed using pAG425GPD-derived constructs 3 ( Supplementary Fig. 5 ).
Block F mutants and constructs encoding cleavage products further confirm that CP1 and CP2 require complete splicing for activity The T69A/H72A double mutation, which resides in conserved block B of the Ssp. dnaE N-intein domain, was used as a convenient splice-disabling mutation. This mutant is predicted to be deficient in processing at the extein/N-intein junction, which is an obligatory first step in dnaE split intein splicing 8, 9 . In some circumstances, interfering with N-intein processing can lead to cleavage at the extein/Nintein junction without concomitant processing at the extein/C-terminal junction 8, 10 . In the SICLOPPS construct, this would represent a cleavage event that would leave the encoded peptide as a linear fusion with the C-intein domain. Blotting for the chitin binding domain tag appended to the N-intein would thus not distinguish this cleavage event from complete splicing.
To ensure that complete splicing is indeed necessary for the function of the CP1 and CP2 constructs, we performed two controls in addition to testing the block B mutants. The first involved making a different mutation that interferes with C-intein processing to verify that C-intein processing is also required for function. By analogy with structural and functional studies on similar inteins, H24 and F26 in conserved block F of the dnaE C-intein domain are responsible for promoting asparagine cyclization in the final processing step at the extein/C-intein junction 9, 11 . Previous work using the SICLOPPS construct has verified that mutation of these residues abolishes splicing in vitro 10, 12 . Point mutagenesis on plasmids encoding HPQ, CP1 and CP2 constructs was used to generate H24L/F26A double mutants, and the resulting plasmids were sequenced to verify the mutation. These H24L/F26A mutants express in yeast but fail to cleave or splice as evident by the presence of only the full-length SICLOPPS construct (Supplementary Fig. 1a) . Further, they fail to suppress α-syn toxicity in yeast (Supplementary Fig.  1b) .
A second set of experiments was undertaken to directly test the possibility that a cleavage event that produces a linear peptide-C-intein fusion is required for CP1 and CP2 function (rather than a full splicing event). To replicate the results of a possible N-intein cleavage event, we decided to co-express the N-intein domain along with a peptide-C-intein fusion. First, to enable detection of expressed peptide-C-intein fusions, we introduced an HA tag to the N-termini of the HPQ, CP1 and CP2 constructs using insertion mutagenesis. These constructs were verified to express and cleave/splice by blotting for either the C-intein HA tag or the N-intein CBD tag (Supplementary Fig. 2a) . The HA tag did not alter the abilities of the CP1 and CP2 constructs to reduce α-syn toxicity (Supplementary Fig. 2b) . Next, we introduced stop codons immediately following the encoded peptide regions of the HA-tagged HPQ, CP1 and CP2 constructs to generate the peptide-C-intein fusion genes. We also cloned the N-intein-CBD fusion from the SICLOPPS construct using Gateway-compatible PCR primers and then used a BP clonase reaction to generate an N-intein-CBD entry vector. This entry vector was used to make a 2μ expression vector using pAG425GPD-ccdB as described 3 . All vectors were sequenced to ensure the presence of the appropriate insertions, mutations, and positioning within newly cloned vectors. Robust expression of each component was verified by blotting for the appropriate tag (Supplementary Fig. 2a) . Expression of the HA-tagged peptide-C-intein fusions alone or with the N-intein-CBD fusion failed to suppress α-syn toxicity (Supplementary Fig. 2b) . Thus, the products of a hypothesized N-intein cleavage event do not phenocopy the full, splice-competent SICLOPPS constructs encoding CP1 and CP2. This control, when combined with the requirements for N-intein processing and C-intein processing demonstrated using point mutants, shows that CP1 and CP2 splice in vivo to produce cyclic peptides that are responsible for the observed phenotypes. HPQstop, HA CP1stop, HA CP2stop) also express in yeast. These latter constructs were co-expressed with a heterologous N-intein-CBD fusion construct to ensure both products of the hypothetical intein cleavage event were present. (B) Spotting assays similar to those shown in Fig. 2b demonstrate that the products of intein cleavage do not suppress α-syn toxicity.
SUPPLEMENTARY FIGURES

Supplementary Figure 3. SAR and minimization data of CP2.
Spotting assays of normalized, serially diluted cells of the screening strain expressing CP2, indicated mutants of CP2, and the negative control HPQ. Each construct was verified to express and splice in yeast. Asterisks denote splice-disabled mutants, which were verified to express but not splice. Similar results were obtained for CP1 (Fig. 3) . The mCP-GFP fusion was transiently expressed in DA neurons and showed robust GFP fluorescence. This representative fluorescence micrograph shows a 7-day-old worm with robust expression of mCP-GFP, with cell bodies (arrowheads) and processes (arrows) visible. Note that not all DA neurons are expected to express mCP-GFP due to mosaic expression of transgenes in non-integrated transgenic animals, and that these effects are averaged out by the large number of animals and multiple transgenic lines used in generating data on α-syn-related phenotypes; this is consistent with methodology used in prior studies [4] [5] [6] [7] . HPQ  CFTNVHPQFANA  ATGGTTAAAGTTATCGGTCGTCGTTCCCTCGGAGT  GCAAAGAATATTTGATATTGGTCTTCCCCAAGACC  ATAATTTTCTGCTAGCCAATGGGGCGATCGCCCAC  AATTGTTTCACCAACGTCCACCCGCAGTTCGCGAA  CGCGTGCTTAAGTTTTGGCACCGAAATTTTAACCG  TTGAGTACGGCCCATTGCCCATTGGCAAAATTGTG  AGTGAAGAAATTAATTGTTCTGTGTACAGTGTTGA  TCCAGAAGGGAGAGTTTACACCCAGGCGATCGCCC  AATGGCATGACCGGGGAGAGCAGGAAGTATTGGAA  TATGAATTGGAAGATGGCTCAGTAATCCGAGCTAC  CTCTGACCACCGCTTTTTAACCACCGATTATCAAC  TGTTGGCGATCGAAGAAATTTTTGCTAGGCAACTG  GACTTGTTGACTTTAGAAAATATTAAGCAAACTGA  AGAAGCTCTTGACAACCATCGTCTTCCCTTTCCAT  TACTTGACGCTGGTACCATTAAAACGACAAATCCT  GGTGTATCCGCTTGGCAGGTCAACACAGCTTATAC  TGCGGGACAATTGGTCACATATAACGGCAAGACGT  ATAAATGTTTGCAGCCCCACACCTCCCTGGCAGGA  TGGGAACCATCCAACGTTCCTGCCTTGTGGCAGCT  TCAATGA 
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